Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease

Apr 4

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease - Chen et al. 2020

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease

Publication Date: 2020.01.15

Authors: CH Chen, BC Lee and CH Lin

Journal: Journal of Parkinson's Disease, vol. 10, no. 1, pp. 77-88, 2020

Citation

CH Chen, BC Lee and CH Lin, "Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease", Journal of Parkinson's Disease, vol. 10, no. 1, pp. 77-88, 2020.

Yiran Gan

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease

Citation

Article Link

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease